SciELO - Scientific Electronic Library Online

 
vol.135 número1Trombosis de la arteria renal después de suspender la terapia anticoagulante en una trasplantada renal con trombofilia: Caso ClínicoQuistes renales, manifestación de diversas patologías índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

BEHRENS P, María Isabel  y  VERGARA E, Fernando. One hundred years of Alzheimer's disease: Immunotherapy a hope?. Rev. méd. Chile [online]. 2007, vol.135, n.1, pp. 103-110. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872007000100015.

In 1906 Alois Alzheimer, described the cerebral lesions characteristic of the disorder that received his name: senile plaques and neurofibrillary tangles. Alzheimer's disease (AD) is now, 100 years after, the most prevalent form of dementia in the world. The longer life expectancy and aging of the population renders it as a serious public health problem of the future. Urgent methods of diagnosis and treatment are required, since the definitive diagnosis of AD continues to be neuropathologic. In the last 30 years several drugs have been approved to retard the progression of the disease; however, there are still no curative or preventive treatments. Although still in experimentation, the visualization of amyloid deposition by positron emission tomography or magnetic resonance imaging will allow in vivo diagnosis of AD. In addition, experiments with the amyloid vaccine are still ongoing, and very recent data suggest that intravenous gammaglobulins may be beneficial and safe for the treatment of AD

Palabras llave : Alzheimer disease; Immunoglobulins, intravenous; Positron-emission tomography; Senile plaques.

        · texto en Español     · pdf en Español